In conclusion, this rather rare case highlights the role of the KIT D816V mutation in combination with NRAS and TP53 mutations in driving the malignancies of ovarian GCT and MCL, as well as the challenges it poses for diagnosis and treatment. This evidence concerns the gene KIT and mantle cell lymphoma.